{"date":"2026-07-22","count":31,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6662-2026-07-22-1959-altjhz","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:59:18","subject":"公告本公司董事會決議配息基準日暨現金發放日","clause":"第14款","fact_date":"2026-07-22","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-07-22 19:59，「公告本公司董事會決議配息基準日暨現金發放日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1941-oshq2u","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:41:55","subject":"代子公司Changsung Softgel System Ltd公告法人董事、監察人發生異動，暨董事異動達三分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:41，「代子公司Changsung Softgel System Ltd公告法人董事、監察人發生異動，暨董事異動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1937-2fgpxv","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:37:22","subject":"代孫公司皇將(上海)包裝有限公司公告法人董事、監察人發生異動，暨董事異動達三分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:37，「代孫公司皇將(上海)包裝有限公司公告法人董事、監察人發生異動，暨董事異動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1927-s1hcjn","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:27:33","subject":"代子公司Changsung Softgel System Ltd公告法人代表人及董事長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:27，「代子公司Changsung Softgel System Ltd公告法人代表人及董事長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1926-jop7x9","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:26:19","subject":"代孫公司皇將（上海）包裝科技有限公司公告董事會推選法人代表人及董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:26，「代孫公司皇將（上海）包裝科技有限公司公告董事會推選法人代表人及董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1924-q1hdtb","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:24:27","subject":"代孫公司CVC Technologies Inc（USA）公告董事會推選法人代表人及董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:24，「代孫公司CVC Technologies Inc（USA）公告董事會推選法人代表人及董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1923-c5ibkh","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:23:14","subject":"代子公司Global Exclusive Co.,Ltd.公告董事會推選法人代表人及董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:23，「代子公司Global Exclusive Co.,Ltd.公告董事會推選法人代表人及董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1921-1vhu1xi","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:21:36","subject":"公告本公司發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:21，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1919-49zolh","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:19:52","subject":"公告本公司永續長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:19，「公告本公司永續長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1918-pb4ygl","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:18:27","subject":"公告本公司董事會決議委任第七屆薪資報酬委員會成員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:18，「公告本公司董事會決議委任第七屆薪資報酬委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1915-1ifbulk","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:15:56","subject":"公告本公司董事會推選副董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:15，「公告本公司董事會推選副董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1914-58zfmu","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:14:29","subject":"公告本公司總經理異動案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:14，「公告本公司總經理異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1912-s0kpz3","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:12:02","subject":"公告本公司董事會推選董事長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:12，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1909-bm0igk","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:09:59","subject":"公告本公司審計委員會任期屆滿改選","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:09，「公告本公司審計委員會任期屆滿改選」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1908-cl3axh","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:08:07","subject":"公告本公司115年股東常會通過解除新任董事及其代表人競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:08，「公告本公司115年股東常會通過解除新任董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1906-1rayw5g","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:06:32","subject":"公告本公司115年股東常會全面改選董事(含獨立董事)當選名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:06，「公告本公司115年股東常會全面改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1903-1jb8ii5","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:03:26","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:03，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-07-22-1901-1vhu1xi","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"19:01:16","subject":"公告本公司發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-07-22 19:01，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4169-2026-07-22-1757-1ej3l8i","company_id":"4169","company":"泰宗","market":"上市","industry":"生技醫療","date":"2026-07-22","time":"17:57:52","subject":"本公司將公布重大訊息，經臺灣證券交易所同意，自115年7月23日起暫停交易","clause":"第40款","fact_date":"2026-07-22","cite_as":"公開資訊觀測站重大訊息：泰宗（4169），2026-07-22 17:57，「本公司將公布重大訊息，經臺灣證券交易所同意，自115年7月23日起暫停交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-07-22-1656-f4atw8","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"16:56:53","subject":"公告本公司股票面額由「新台幣10元」變更為「新台幣5元」公告期間：115年7月22日至115年10月21日","clause":"第53款","fact_date":"2026-06-24","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-07-22 16:56，「公告本公司股票面額由「新台幣10元」變更為「新台幣5元」公告期間：115年7月22日至115年10月21日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2026-07-22-1637-loss66","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2026-07-22","time":"16:37:08","subject":"公告本公司民國115年第2季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-07-22","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2026-07-22 16:37，「公告本公司民國115年第2季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2026-07-22-1619-1rk5n5v","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"16:19:38","subject":"公告本公司115年度第二季合併財務報告董事會預計召開日期為115年07月30日","clause":"第31款","fact_date":"2026-07-22","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2026-07-22 16:19，「公告本公司115年度第二季合併財務報告董事會預計召開日期為115年07月30日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2026-07-22-1541-1tuelu0","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"15:41:25","subject":"公告本公司115年第二季財務報告董事會召開日期為115年7月30日","clause":"第31款","fact_date":"2026-07-22","cite_as":"公開資訊觀測站重大訊息：安克（4188），2026-07-22 15:41，「公告本公司115年第二季財務報告董事會召開日期為115年7月30日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-07-22-1541-1j6hbzf","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"15:41:04","subject":"公告本公司訂定除息基準日及調整配息率等相關事宜","clause":"第14款","fact_date":"2026-07-22","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-07-22 15:41，「公告本公司訂定除息基準日及調整配息率等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2026-07-22-1537-109jtcw","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"15:37:37","subject":"本公司受邀參加元大證券舉辦之線上法說會","clause":"第12款","fact_date":"2026-08-06","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2026-07-22 15:37，「本公司受邀參加元大證券舉辦之線上法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2026-07-22-1535-1j7xe","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"15:35:52","subject":"公告115年第二季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-07-22","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2026-07-22 15:35，「公告115年第二季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2026-07-22-1523-14u4t38","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2026-07-22","time":"15:23:00","subject":"公告華上生醫自主開發新一代表觀免疫調控抗癌候選新藥GNTbm-38，取得印度發明專利","clause":"第44款","fact_date":"2026-07-22","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2026-07-22 15:23，「公告華上生醫自主開發新一代表觀免疫調控抗癌候選新藥GNTbm-38，取得印度發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-07-22-1509-sqgrt0","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-07-22","time":"15:09:19","subject":"公告本公司法人董事代表人異動","clause":"第6款","fact_date":"2026-07-22","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-07-22 15:09，「公告本公司法人董事代表人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-07-22-1503-1p0bu8s","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"15:03:37","subject":"公告本公司股票面額變更相關事宜","clause":"第53款","fact_date":"2026-07-22","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-07-22 15:03，「公告本公司股票面額變更相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-07-22-1502-vw3ox6","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"15:02:35","subject":"公告本公司董事會決議通過股票面額變更之換發股票基準日","clause":"第11款","fact_date":"2026-07-22","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-07-22 15:02，「公告本公司董事會決議通過股票面額變更之換發股票基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-07-22-1501-1j1h6xh","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-07-22","time":"15:01:26","subject":"公告本公司董事會決議通過股票面額變更之換發股票作業計畫","clause":"第36款","fact_date":"2026-07-22","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-07-22 15:01，「公告本公司董事會決議通過股票面額變更之換發股票作業計畫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}